Honolulu Clinic Highlights Modern Cupping Therapy Honolulu, United States - February 23, 2026 / Dynamic Stretch Therapy ...

Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite no difference in platelet count recovery End-of-Phase ...

Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite ...

LOS ANGELES, CA, UNITED STATES, February 10, 2026 /EINPresswire.com/ -- Pulmonary embolisms affect 370,000 patients per ...

By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Acquires 12-LOX Inhibitor VLX-1005 for the Treatment of HIT In December 2025, Cadrenal Therapeutics, Inc.

Smartwatch screening detects atrial fibrillation earlier and more often, offering a scalable strategy to improve stroke prevention and clinical care globally.

Introduction Atrial fibrillation (AF), with a prevalence of 1–2%, is the most common cardiac arrhythmia. AF is associated with a fivefold increased risk of cardioembolic events; approximately 20% of ...

The “gold standard” treatment for AFib that will make it increasingly possible was first performed in Utah at St. Mark's Hospital.

Please provide your email address to receive an email when new articles are posted on . Abridged dual therapy followed by direct oral anticoagulant monotherapy after PCI may be safe vs. 1 year of dual ...

Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with atrial fibrillation after implantation of a drug-eluting ...

Treatment with anticoagulants, also known as blood thinners, does not extend survival in people with pulmonary arterial hypertension (PAH), according to a large French study. These findings were ...